Skip to main content
. 2022 Nov 8;23:1–15. doi: 10.1016/j.bioactmat.2022.10.004

Fig. 6.

Fig. 6

In vivo anti-tumor efficiency of different treatments on peritoneal carcinomatosis (PC) model of gastric cancer. (A) Schematic diagram of the PC model establishment and therapy schedule. (B) Bioluminescence images of mice after therapy. (C) Quantified bioluminescence intensity of the mice treated with different formulations. Data are presented as mean ± sd (n = 5). (D) Body weight curves after different treatments. Data are presented as mean ± sd (n = 7). (E) Gross examination of peri-gastric and mesenteric tumor nodules on day 13 post-treatment. The white arrows denote tumors. Scale bar: 1 cm. (F) Survival curves of mice after various treatments. Data are presented as mean ± sd (n = 5). (G) H&E staining of the main organs of mice after various treatments on day 13. The black arrows denote abnormal tissue. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.